z-logo
open-access-imgOpen Access
A Point Mutation in theagrLocus rather than Expression of the Panton‐Valentine Leukocidin Caused Previously Reported Phenotypes inStaphylococcus aureusPneumonia and Gene Regulation
Author(s) -
Amer E. Villaruz,
Juliane Bubeck Wardenburg,
Burhan Khan,
Adeline R. Whitney,
Daniel E. Sturdevant,
Donald J. Gardner,
Frank R. DeLeo,
Michaël Otto
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/604728
Subject(s) - panton–valentine leukocidin , staphylococcus aureus , leukocidin , pathogenesis , biology , phenotype , locus (genetics) , virulence , gene , point mutation , microbiology and biotechnology , genetics , mutation , methicillin resistant staphylococcus aureus , immunology , bacteria
sThe role of Panton-Valentine leukocidin (PVL) in Staphylococcus aureus pathogenesis is controversial. Here, we show that an unintended point mutation in the agr P2 promoter of S. aureus caused the phenotypes in gene regulation and murine pneumonia attributed to PVL by earlier investigators. In agreement with other studies that failed to detect similar effects of PVL using community-associated methicillin-resistant S. aureus strains, we found no significant effect of PVL on gene expression or pathogenesis after we repaired the mutation. These findings provide further evidence that PVL does not have a major impact on S. aureus pathogenesis. Moreover, our results demonstrate that a single nucleotide polymorphism in an intergenic region can dramatically affect bacterial physiology and virulence. Finally, our work emphasizes the need to frequently evaluate the integrity of the S. aureus agr locus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom